RBM-007 in Subjects witH ExudatIve Age-related Macular Degeneration

Clinical trial NCT03633084 · COMPLETED

Trial details

NCT number: NCT03633084
Sponsor: Ribomic USA Inc
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Age-related Macular Degeneration

Start date: 2018-08-29
Primary completion: 2019-06-26
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.